相似文献
1
The Pharmacogenomics of a Mutation 'Hotspot' for the Short QT Syndrome.
JACC Clin Electrophysiol. 2017 Jul;3(7):744-746. doi: 10.1016/j.jacep.2016.12.024.
2
Pharmacogenetic issues in thorough QT trials.
Mol Diagn Ther. 2006;10(3):153-62. doi: 10.1007/BF03256454.
3
Molecular basis of arrhythmias.
Circulation. 2005 Oct 18;112(16):2517-29. doi: 10.1161/CIRCULATIONAHA.104.494476.
4
Pharmacogenetics and cardiac ion channels.
Vascul Pharmacol. 2006 Feb;44(2):90-106. doi: 10.1016/j.vph.2005.07.013. Epub 2005 Dec 15.
5
Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.
Expert Opin Pharmacother. 2008 Mar;9(4):537-49. doi: 10.1517/14656566.9.4.537.
6
Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome?
J Mol Cell Cardiol. 2006 Sep;41(3):421-3. doi: 10.1016/j.yjmcc.2006.06.070. Epub 2006 Jul 25.
7
Short QT syndrome: a case report and review of literature.
Resuscitation. 2006 Oct;71(1):115-21. doi: 10.1016/j.resuscitation.2006.03.011. Epub 2006 Aug 30.
8
[Mutations in the heart's pacemaker channels--a new cause of sick sinus node syndrome and long-QT syndrome].
Ugeskr Laeger. 2008 Mar 10;170(11):929-33.
9
In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
J Cardiovasc Electrophysiol. 2007 Nov;18(11):1157-60. doi: 10.1111/j.1540-8167.2007.00925.x. Epub 2007 Aug 16.
10
Pharmacogenetics of drug-induced arrhythmias: a feasibility study using spontaneous adverse drug reactions reporting data.
Pharmacoepidemiol Drug Saf. 2006 Feb;15(2):99-105. doi: 10.1002/pds.1194.
引用本文的文献
1
Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG 'hotspot' mutation.
Biochem Biophys Res Commun. 2022 Mar 12;596:49-55. doi: 10.1016/j.bbrc.2022.01.057. Epub 2022 Jan 21.
本文引用的文献
1
New echocardiographic insights in short QT syndrome: More than a channelopathy?
Heart Rhythm. 2015 Oct;12(10):2096-105. doi: 10.1016/j.hrthm.2015.05.024. Epub 2015 May 20.
2
Novel insight into the natural history of short QT syndrome.
J Am Coll Cardiol. 2014 Apr 8;63(13):1300-1308. doi: 10.1016/j.jacc.2013.09.078. Epub 2013 Nov 28.
3
Long-term follow-up of a pediatric cohort with short QT syndrome.
J Am Coll Cardiol. 2013 Mar 19;61(11):1183-91. doi: 10.1016/j.jacc.2012.12.025. Epub 2013 Jan 30.
4
A short story of the short QT syndrome.
Cleve Clin J Med. 2013 Jan;80(1):41-7. doi: 10.3949/ccjm.80a.12029.
5
The short QT syndrome.
J Interv Card Electrophysiol. 2011 Jun;31(1):25-31. doi: 10.1007/s10840-011-9566-0. Epub 2011 Apr 14.
6
The short QT syndrome: proposed diagnostic criteria.
J Am Coll Cardiol. 2011 Feb 15;57(7):802-12. doi: 10.1016/j.jacc.2010.09.048.
7
Short and long QT syndromes: does QT length really matter?
J Electrocardiol. 2010 Sep-Oct;43(5):396-9. doi: 10.1016/j.jelectrocard.2010.07.009.
8
Short QT syndrome: from bench to bedside.
Circ Arrhythm Electrophysiol. 2010 Aug;3(4):401-8. doi: 10.1161/CIRCEP.109.921056.
9
Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.
Br J Pharmacol. 2008 Nov;155(6):957-66. doi: 10.1038/bjp.2008.325. Epub 2008 Aug 25.
10
Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants.
Circulation. 2008 Feb 19;117(7):866-75. doi: 10.1161/CIRCULATIONAHA.107.752220. Epub 2008 Feb 4.
Zotero 插件